These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity. Tsagarakis S, Vasiliou V, Kokkoris P, Stavropoulos G, Thalassinos N. Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315 [Abstract] [Full Text] [Related]
5. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ. Clin Endocrinol (Oxf); 1996 Jun; 44(6):717-22. PubMed ID: 8759185 [Abstract] [Full Text] [Related]
8. Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism. Mojtahedzadeh M, Shaesteh N, Haykani M, Tran JLA, Mangubat M, Shahinian HK, Nachnani R, Zopey M, Saidian J, Thomas A, Lee ML, McCutcheon IE, Friedman TC. Horm Metab Res; 2018 Jun; 50(6):453-461. PubMed ID: 29719879 [Abstract] [Full Text] [Related]
11. Screening for Cushing's syndrome in obese patients. Tiryakioglu O, Ugurlu S, Yalin S, Yirmibescik S, Caglar E, Yetkin DO, Kadioglu P. Clinics (Sao Paulo); 2010 Jun; 65(1):9-13. PubMed ID: 20126340 [Abstract] [Full Text] [Related]
12. Single-dose four hour dexamethasone suppression test in normal men and its application for the diagnosis of Cushing's syndrome. Nishida S, Matsumura S, Horino M, Oyama H, Tenku A. Steroids; 1976 Sep; 28(3):411-21. PubMed ID: 982498 [Abstract] [Full Text] [Related]
13. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome]. Tang TJ, Liu YP, Yu YR. Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108 [Abstract] [Full Text] [Related]
14. Comparison of efficacy between 1 mg overnight dexamethasone suppression test and 2-day low dose dexamethasone suppression test for diagnosis of Cushing's syndrome. Kungpanichkul N. J Med Assoc Thai; 2010 Jan; 93(1):27-33. PubMed ID: 20196407 [Abstract] [Full Text] [Related]
15. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism. Friedman TC. Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537 [Abstract] [Full Text] [Related]
19. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome. Barrou Z, Guiban D, Maroufi A, Fournier C, Dugué MA, Luton JP, Thomopoulos P. Eur J Endocrinol; 1996 Jan; 134(1):93-6. PubMed ID: 8590965 [Abstract] [Full Text] [Related]
20. Development of diagnostic algorithm for Cushing's syndrome: a tertiary centre experience. Efthymiadis A, Loo H, Shine B, James T, Keevil B, Tomlinson JW, Pal A, Pofi R. J Endocrinol Invest; 2024 Oct; 47(10):2449-2459. PubMed ID: 38536658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]